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Investiqation of the Immunization Practices of a Small Town 
Private Provider Pediatric Group 
Ie Abstract 
Recent epidemics of vaccine-preventable childhood diseases 
among preschool children in the united states have brought the 
nation's immunization practices under scrutiny. Undervaccination 
of preschool children has lead to current epidemics of measles and 
increases in the number of children who have acquired pertussis 1 
both of which have the greatest complications when disease occurs 
early in life (appendix B) . 
Current trends in the research of immunization administration 
focus primarily on the delivery of vaccinations. Many scientist 
and doctors have hypothesized on solutions to the problems 
surrounding immunizations, searching for more effective ways of 
delivery. Issues of cost of vaccine and missed opportunities are 
currently prevalent in discourse about immunizations. 
The purpose of this project was to investigate the 
immunization practices in a small town private provider pediatric 
group (PPPG), to assess problems that might diminish efficiency and 
accuracy of the administration of vaccinations in the practice, to 
propose possible solutions to those problems, and to hypothesize on 
a national solution to the enigma surrounding immunizations. 
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II. Introduction 
Much has changed since 1796 when Edward Jenner first 
inoculated James Phipps with cowpox and subsequently began the 
practice of immunization. contemporary milestones have included 
the licensure of the first recombinant vaccine (Hepatitis B), the 
last indigenous case of smallpox in 1977, the final wild-virus 
polio case in the western Hemisphere in 1991, and the elimination 
of polio in the Americas. 2 
Science's ability to manipulate the human body's immune 
system, to train it, has become one of the greatest, and perhaps 
one of the most taken for granted preventive health techniques. 
The development and use of vaccines have made major contributions 
to the health of our nation's children throughout this century. 3 
Immunizations are now available to protect children against a host 
of diseases that were less than a generation ago significant causes 
of suffering and death. 4 Effectively immunizing all children is 
a fundamental goal of our country's health care system. 5 However, 
the system of delivering vaccines has not progressed as effectively 
as the technology of vaccine development. 6 Recent government 
proposals, including the Comprehensive Child Immunization 
Initiative advanced by President Clinton address this issue, 
focusing on the low levels of immunization among America's 
preschoolers, especially those age 0 to 2 years. Previous studies 
have identif ied a "toddler gap", in which the percentage of 
children who are up-to-date on vaccinations falls between the first 
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and second years of life. 7 Most of the protection gained from the 
battery of immunizations currently recommended by the Centers for 
Disease Control and Prevention in Atlanta (appendix E) "should be 
received by two years of age". 8 Immunization of preschool 
children is intended to provide protection to the group most 
vulnerable to the diseases. Approximately 80% of the recommended 
childhood immunizations should be received by 2 years of age. 9 
Studies reported in both the "Journal of the America Medical 
Association" and the "Morbidity and Mortality Weekly Report" (MMWR) 
indicate, however, that currently only forty to fifty percent of 
the nation's preschoolers have received the recommended battery of 
protection 10 11 In 1993," an estimated 500,000 U.S. children aged 
19-35 months lack [ed] at least three doses of DTP; 1 million 
need[ed] one or more doses of polio vaccine, and 750,000 need[ed] 
one or more doses of MMR. It 12 Only 60% of a random sample of 
children conducted in two states were fully up-to-date by their 
second birthday according to one study. 13 Also, another study by 
Mustin et. al., found that successful completion of the recommended 
primary vaccine series in the first 7 months of life was only 46% 
in white infants and 34% in black infants, even though 82% of the 
white infants and 75% of the black infants had an adequate number 
of well-child visits. 14 These depressed levels have not been 
without ramifications. On-time initiation of immunization is 
especially important in the prevention of Pertussis (whooping 
cough), which has it's highest morbidity in the first year of life. 15 
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In 1993, according to the Centers for Disease Control and 
Prevention, the number of cases of pertussis reported was the 
highest of any year since 1967, and 36% of those cases occurred in 
a patient population 6 months of age or younger. 16 Similarly, the 
principal cause for the measles epidemic (1989-1990) was failure to 
provide vaccine to children at the recommended age. Thus, those 
most vulnerable to this disease remained highly susceptible and 
highly contagious. n From 1989-1990, over 28,000 cases of measles 
were reported in the united States, and there were 132 related 
deaths. In 1989 alone, more than 18,000 cases were reported and 41 
deaths occurred- the largest number of deaths from measles to occur 
in the united States in over two decades. 18 
Gaining insight into these obvious shortcomings in the 
immunization policies of our health care providers and some of the 
reasons for these deficits in care was one focus of this 
investigation. Data was obtained through a review of the 
literature, through discussions with Dr. William Cook, Jr., M.D., 
on the topic of immunizations, and through sampling a statistically 
relevant number of active two-year old patients in a PPPG to 
determine the degree to which they were up-to-date. Current levels 
of immunization were assessed and possible factors influencing the 
administration of vaccine were investigated. Finally, a hypothesis 
was formed describing one method that might be implemented to 
create both a national tracking system for childhood immunizations 
and reduce cost of vaccine. 
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III. Materials and Methods 
For the purposes of this study the investigator used the 
Clinical Assessment Software Application Program (CASA) developed 
by the National Immunization Programs of the Center for Disease 
Control and Prevention in Atlanta. The program, which is readily 
available through the Bureau of Immunizations, Commonwealth of 
Virginia, determined the number of charts to be reviewed and the 
starting and ending points for review. (appendix D). Subjects were 
selected who were born between 12-20-91 and 12-18-92 and were also 
active patients of the PPPG in Radford, Virginia. The said 
practice is located in a prosperous area of the Blue Ridge 
Mountains of Virginia and serves patients from both the immediate 
area and from as far away as sixty miles. All six physicians, 
whose ages range from 36 to 58, are board certified by the American 
Board of Pediatrics. The practice is accustomed to providing a 
full range of general pediatric medical care for its patients, and 
is adjacent to the local hospital, Radford Community, which has 150 
beds. Although two major universities are located within twenty 
miles of the practice, the environment is basically that of a small 
town (population approximately 16,000). The area has a number of 
large industries including an army arsenal, a heavy truck assembly 
plant, a foundry, a bearing manufacturing facility, and a plant 
producing high tech motors. Local schools rank well above the 
average on statewide achievement test and many of the students go 
on to college. The practice is currently open to new patients and 
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provides services to those on Medicaid. Immunization policies 
include administration of vaccination primarily during well-child 
visits. The immunization schedule followed by the practice mirrors 
the recommendations of the American Board of Pediatrics 
(appendix e). By the age of two, it is anticipated that four DTP 
(Diphtheria, Tetanus, and Pertussis Vaccine), three OPV (Oral Polio 
Vaccine), one MMR (Measles, Mumps, and Rubella Vaccine), and four 
HIB (Haemophilus Influenza B Vaccine) vaccinations shall have been 
administered. For the purposes of this study, this is considered 
up-to-date. Administration of the HEP B vaccine became standard 
procedure for the practice in 1993. Subsequently, patients 
selected for this study may not have been vaccinated with HEP B. 
Although the vaccination levels of HEP B were not specifically 
addressed by this investigation, any conclusions that are drawn 
concerning the vaccinations investigated can be assumed to be 
pertinent to HEP B as well. At the time of the study, the practice 
did not have a system in place to notify patients who were not up-
to-date or who missed appointments. Also, the practice had no 
method in place for obtaining vaccination information from the 
local county health department, to which it refers a large number 
of its patients for immunization services. 
Of the nine hundred and seventy one patients who were born 
between 12-20-91 and 12-18-92, one hundred and ninety charts were 
reviewed. This number was deemed statistically relevant by the 
CASA after the site data (collected at the PPPG) was entered into 
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the program in a manner similar to the example in appendix D. In 
order to obtain a random sample, a computer printout of active 
patients born between 12-20-91 and 12-18-92 was generated. The 
investigator, under the direction of the CASA, began sampling with 
the fourth patient on the computer generated list and then every 
fifth patient's chart was reviewed. The charts were reviewed over 
a period of two weeks. Information was gathered that included the 
patient's last name, birth date, medicaid status, and the dates of 
administration for each of the vaccinations in the recommended 
battery. After the initial review those patient's whose records 
were incomplete were reviewed a second time in attempts to obtain 
more immunization information. The missing information was 
obtained in all cases possible. Acquisition of this data was 
accomplished via telephone. Calls were placed to patients' 
guardians, local and state health departments, and to other 
pediatricians and/or family physicians in the surrounding area. 
Finally, the data were analyzed to ascertain the degree of 
successful execution of vaccination, to assess problems that might 
diminish efficiency and accuracy of the administration of 
vaccinations in the practice, to propose possible solutions to 
those problems, and to hypothesize on the implications that any 
conclusions drawn might have on similar practices in America. 
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IV. Results and Recommendations 
This study was designed to investigate the immunization 
practices of a PPPG. One hundred and ninety charts were reviewed. 
Of those one hundred and ninety patient charts, one hundred and ten 
were fully up-to-date. Recall that up-to-date for the purposes of 
this study indicates that the patient has completed four DTP, three 
OPV, one MMR, and four HIB vaccinations by age two. The remaining 
eighty patients were subjected to a second review and missing 
information was obtained in all cases possible. Acquisition of 
this information was accomplished via telephone leading to the 
discovery of an additional thirteen patients subject to this study 
who were also up-to-date. The remaining sixty seven patients whose 
records were incomplete had either transferred out of the practice, 
seventeen, had returned only for the two week newborn check-up, 
five, had visited the office only during illness, fourteen, were 
referred to the local health department, twelve, or were lacking 
information and were untraceable, nineteen. The PPPG thus had an 
above average efficiency for administration of immunizations 
(64.7 %) when compared with national levels of efficiency (60.0 % 
according to the study by Bobo, et al.). The immunization 
information, however, was not readily accessible. The lack of 
accessibility of the information led to incomplete records and poor 
data recovery during the initial review of charts, causing the 
practice to appear that it was not doing as well as it really was. 
The obvious deficiencies in the exchange of immunization 
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information between providers, particularly between the PPPG and 
the local health department, became a focus of this study. 
Incomplete vaccination information in the charts of private 
providers is a direct result of referral. Approximately half of 
u.s. children receive their immunizations from private physicians; 
the other half receive their immunizations in the public sector, 
but many of these obtain their well-child care from private 
physicians. 19 20 Parents utilize these health departments for 
numerous reasons. Primarily, those who cannot afford immunization 
are more likely to express a preference to take their child to the 
health department. 21 Pediatricians often will refer patients to 
these departments when parents indicate financial hardships.22 The 
cost of completion of the recommended series of vaccinations in a 
private sector setting is approximately $324.00. The cost for the 
same series in the public sector is $122.00. Patients may be 
responsible for all of the cost, none of the cost, or a percentage 
of the cost. 23 
In a "best case scenario", referral of this nature would not 
be problematic. Parents would take their children to the health 
departments and the necessary immunizations would be given. Then 
the parents would return to the pediatrician's office with the 
immunization information and charts would be updated. This, 
however, is often not the case. Parents whose children are seen at 
the pediatrician's office and are referred may never go to the 
health departments to acquire vaccination. Often, even if they do 
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go, the information is never shared with the pediatrician's office. 
This type of patient population can serve as fuel for problems 
similar to the recent measles and pertussis epidemics. The 
possibility that referral reduces the likelihood that a child will 
receive immunizations is troubling. ~ Each time a child leaves 
his/her physician's office without receiving needed vaccines, 
primary care is fragmented and an opportunity to immunize is 
missed. 25 The study by Mustin et al (see footnote 15) addresses 
this issue when it sites that at seven months of life "only 46% of 
white infants and 34% of black infants" had completed the 
recommended series of vaccinations "even though 82% of white 
infants and 75% of black infants had an adequate number of well-
child visits." The American Academy of Pediatrics believes that 
medical care of infants, children, and adolescents should be 
accessible, continuous and comprehensive. 26 Referral due to cost 
has lead to incomplete medical records in the offices of the 
primary provider on both a national level and in the PPPG reviewed 
by this study and lithe results confirm the importance of 
physicians' concerns over the cost of vaccines to their patients as 
the most important factor leading to referrals. II v 
Currently, the nations' direction regarding immunizations is 
focused on creating a national tracking system specifically 
designed to allow health care providers the ability to obtain and 
to give childhood immunization information freely. Theoretically, 
such a system would allow any health care provider (HCP) to access 
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a national data base. The HCP could enter vaccination information 
on a specific patient and also obtain information. 
HPCs the capability to insure that all of 
immunizations were fully up-to-date, regardless 





vaccinations were given. This idea has not been pursued with much 
vigor recently because of beliefs that "computerized tracking 
systems are likely to require large investments in new equipment 
and training and considerable behavioral changes among private 
health-care providers and the public at large." 28 Devoid of a 
national tracking system, efforts must be made within each practice 
to better facilitate exchange and recording of immunization 
information. Al though there are many methods by which this type of 
reorganization might occur, the following are the recommendations 
of this investigator to the PPPG which was the focus of this 
investigation. This recommended course of action is specifically 
targeted for this practice although it may be applicable in part or 
whole to other organizations who are trying to better facilitate 
the handling of vaccination information devoid of a national 
tracking system. 
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v. Recommended Course of Action 
1. WHO: All children born after 12-31-95 should be subject to the 
new procedures. 
2. EDUCATION: At the time of the first visit with a patient (i.e. 
the creation of a patient chart) parents should be informed 
about the necessity of timely vaccinations. Inadequate maternal 
education regarding vaccinations has been shown to be related to 
delayed immunizations. 
3. WRITTEN: During visits, when vaccinations are given, the 
subsequent shot information should be written in an area 
provided for at the front of the chart and initialed by the 
nurse administrator. 
4. VISUAL: Once a vaccination is given, or information is obtained 
regarding administration at another health care center, a 
colored sticker should be placed on the cover of each chart and 
the date the immunization was given should be written in the 
center of the sticker. The colored stickers would provide an 
immediate visual cue of the patient's vaccination history 
allowing the parents, the nurse, and the physician to 
immediately assess the needs of the patient. The colors could 
be similar to those in table A. 
TABLE A 
VACCINE DTP MMR OPV HIB HEB 
COLOR RED GREEN BLUE ORANGE YELLOW 
It should be noted here that the placement of the sticker 
might be an exciting event for the child. 
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5. REFERRALS: Those patients who choose to have their immunizations 
administered in the public sector, but will continue to see the 
pediatrician for sick-visits should be given the first battery 
of immunizations. Their chart should be placed in an atypical 
colored folder and they should be asked to sign a postcard 
similar to the one below. 
I give Child-Adolescent Health Associates of the New River 
Valley permission to notify the health department of my choice 
to obtain my child's immunizations there. Furthermore, I give 
both the health department and Child-Adolescent Associates 
permission to exchange that immunization information. 
NAME: (please print) --------------------------------------------
SIGNED: ----------------------------------------------------------
6. HEALTH DEPARTMENTS: The local health departments should keep a 
list of patient's primary care providers and should record any 
vaccinations given to a child on that list. 
7. FOLLOW-UP: At the conclusion of each week, one nurse should be 
assigned the task of phoning the local health departments and 
updating the office charts with new vaccination information. 
Implementation of such a procedure could allow the PPPG to 
have more accurate immunization information in the near future. 
This type of organization could lead to better centralization of 
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vaccination information even in the absence of a national tracking 
system. possible increases in the number of children who are fully 
up-to-date and decreases in the number of those who receive 
duplicate vaccinations might also occur. Organization of this 
type, nonetheless, would only be a compromise solution to the 
current issues surrounding immunizations. Many relevant issues 
would not be addressed. For example, the central problem of 
referrals due to cost, which has lead to the deficiencies in the 
immunization information found within many of the charts of the 
primary care providers would still prevail. Also, although the 
aforementioned recommendations would allow for exchange of 
information on a local level, they might not allow for exchange of 
the information on a regionally or national level. Thus, although 
enhanced exchange of information must currently begin at the local 
level, real advances in the solutions to national immunization 
issues will not occur until a program is initiated on a national 
level through a tracking system that also reduces cost of vaccine. 
VI. Point of Departure: The Ideal Solution 
The solution to the problems surrounding immunization 
administration may be simple, although a few assumptions have to be 
made. It must be assumed that any physician who wished to 
participate would have access to a computer with a modem. It must 
also be assumed that political bipartisanship would be achieved 
regarding this issue. With these assumptions made, let's look at 
a solution. 
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The federal government would have to shoulder the 
responsibility for initial acquisition of all vaccine from the drug 
companies. The drug companies would readily accept this idea 
because they could sell in bulk and would acquire government 
contracts. Currently the federal government accounts for much of 
the vaccine sold in the united states. As previously mentioned , it 
sells vaccine to health departments at a reduced price. In this 
model, the federal government would sell a specific amount of the 
purchased vaccine to any doctor who would administrate it. The 
government would sell it to all health care providers at the same 
reduced price (appendix C). The doctor could thus purchase a 
specific amount of the vaccine at a reduced rate and immunize 
children a price comparable to those incurred at health 
departments. This would solve the issue of missed opportunities 
due to cost. 
The solution to the tracking problem could easily be related 
to the solution to the missed opportunities. The doctor would 
acquire a specific amount of vaccine at the reduced price. The 
amount of vaccine purchased by the doctor would be recorded. After 
each immunization given using government acquired vaccine, the 
health care provider, in this specific case the doctor, would be 
required to report it to the federal government agency in charge of 
immunization records and vaccine information. This agency could be 
the social security department. Currently, the social security 
department has access to the social security numbers of all of our 
citizens. 
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The network already exists on the local and state 
levels. Thus, in theory, all children born in this country have 
their own social security number soon after birth. In practice, a 
large percentage of the newborn population are assigned social 
security numbers early in life because these numbers are necessary 
if the parent(s) wish to claim their children as dependents on 
income tax forms. As a result, the Social Security Department 
already has all of the tracking capabilities in place. The report 
from the health care providers' office could be made electronically 
to the regional social security department. The report would 
contain the social security number of the child who received the 
vaccination, the date the vaccination was given, who gave it to the 
child, and the type of vaccination that was given. 
When the health care provider wished to reorder vaccine, the 
only vaccine that would be replaced at the reduced price would be 
that which was given and reported to the social security 
department. Any vaccine that was used and not reported would be 
sold at a higher price. Therefore, by controlling the entire 
supply of vaccine, by holding health care providers accountable for 
a specific amount of vaccine, and by charging health care providers 
higher prices when they failed to report immunizations given, the 
federal government would be capable of tracking the immunization 
histories of our young and hopefully assure that those children who 
were underimmunized would be found and immunized. 
The political issues surrounding the need for solutions to 
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immunization problems of our nation are few. Most agree that 
something must be done. However, the resolution is not such a 
comfortable topic. The scope of the social security department, 
patient's privacy, purchasing and distribution of vaccine, and the 
new roles of health departments and drug companies are prevalent 
issues that would have to be addressed even in the simplistic model 
proposed by this investigator. Most of these types of issues make 
politicians uncomfortable. However, if no real efforts are taken 
to increase the effectiveness of immunization administration, our 
children are the ones who will ultimately suffer. 
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Most complications of diphtheria and deaths are attributable 
to the effects of the toxin. The severity of the disease and 
complications is generally related to the extent of local disease. 
The toxin, when absorbed, affects organs and tissues distant from 
the site of invasion. The most frequent complications of 
diphtheria are: 
Myocarditis: 
Abnormal cardiac rhythms can occur early in the course of the 
illness or weeks later, and can lead to heart failure. J;:f 
myocarditis occurs early, it is often fatal. 
Neuritis: 
This complication usually affects motor nerves and usually 
clears completely. Paralysis of the soft palate is most frequent 
during the third week of illness. Eye muscles, limbs, and 
diaphragm paralysis can occur after the fifth week. Secondary 
pneumonia and respiratory failure may result from diaphragmatic 
paralysis. 
other complications include otitis media and respiratory 
insufficiency due to airway obstruction, especially in infants. 
Death: 
The case-fatality rate for diphtheria is 5%-10%, with higher 
death rates (up to 20%) in persons <5 and >40 years of age. The 




Laryngospasm (spasm of the vocal cords) and/or spasm of the 
muscles of respiration leading to interference with breathing. 
Fractures in the spine or long bones are a result of sustained 
contractions and convulsions. 
Hyperac~ivity of the autonomic nervous system may lead to 
hypertension and/or an abnormal heart rhythm. 
Comas may also occur in association with tetanus. 
Secondary infections, may· include sepsis, indwelling 
catheters, hospital acquired pneumonia, and decubitus ulcers. 
Pulmonary embolism is particularly a problem in drug addicts 
and elderly patients. 
Aspiration pneumonia is a common late complication of tetanus, 
found in 50%-70% of autopsied cases. 
Death: 
Approximately 30% of reported cases are fatal. In the united 
states, most deaths occur in persons >50 years of age. In about 
20% of tetanus deaths, no obvious pathology is identified and death 
is attributable to the direct effects of tetanus toxin. The course 




Young infants are at the highest risk for acquiring pertussis 
and pertussis-associated complications. The l'(lost common 
complication and the cause of most deaths is secondary bacterial 
pneumonia. Data for 1989-1991 indicate that pneumonia occurred 
among 12% of all reported pertussis cases and among 16% of infants 
<6 months of age. 
Neurological complications such as seizures and encephalopathy 
(a diffuse disorder of the brain) may occur as a result of hypoxia 
(reduction of oxygen supply) from coughing, or possibly from the 
toxin. Neurological complications of pertussis are more common 
among infants. 
Other less serious complications include otitis media, 
anorexia, and dehydration. Complications resulting from pressure 
effects of severe paroxysms include pneumothorax, epistaxis, 
subdural hematomas, hernias, and rectal prolapse. 
In the united states from 1989 through 1991, 41% of all 
reported pertussis cases were hospitalized, including 69% of 
infants. From 1989 through 1991, 20 deaths due to pertussis (case-
fatality rate=O. 2%) 
highest in infants 
were reported. 
younger than 6 
The case-fatality rate was 
months of age (0.2%) and 




Approximately 30% of reported measles cases have one or more 
complications. Complications of measles are more common among 
children <5 and adults >20 years of age. 
Diarrhea: 
From 1985 through 1992, diarrhea was reported in 8% of 
reported cases, making this the most commonly repo~ted complication 
of measles. 
otitis Media: 
otitis media is reported in 7% of reported cases, and occurs 
almost exclusively in child. 
Pneumonia: 
Pneumonia (6% of the reported cases) may be viral or 
superimposed bacterial, and is the most common cause of death. 
Encephalitis: 
Acute encephalitis is reported in approximately 0.1% of the 
reported cases. Onset generally occurs 6 days after rash onset 
(range 1-15 days), and is characterized by fever, headache, 
vomiting, stiff neck, meningeal irritation, drowsiness, 
convulsions, and coma. Cerebrospinal fluid shows pleocytosis and 
elevated protein. Case fatality rate is approximately 15%. Some 




Seizures (with or without fever) are reported in 0.6% to 0.7% 
of reported cases. 
Subacute sclerosing panencephalitis (SSPE): 
Subacute sclerosing panencephalitis (SSPE) is a rare 
degenerative central nervous system disease believed to be due to 
persistent measles virus infection of the brain. Average onset 
occurs 7 years after measles (range 1 month to 27 years), and 
occurs in five to ten cases per million reported measles cases. 
The onset is insidious, with progressive deterioration of behavior 
an6 intellect, followed by ataxia (awkwardness) I myoclonic 
seizures, and eventually death. 
Measles during pregnancy: 
Meas~es during pregnancy results in a higher risk of 
prematurity and spontaneous abortion. Birth defects (with no 
definable pattern of malformation) have been reported rarely, 
without confirmation that measles was the cause. 
Death: 
Death from measles has been reported in approximately 1-2 per 
1,000 reported cases in the United states in recent years. As with 
other complications of measles, the risk of death is higher in 
young children and adults. Pneumonia accounts for about 60% of the 
deaths. The most common causes of death are pneumonia in children 




Central nervous system (CNS) involvement in the form of 
aseptic meningitis (inflammatory cells in cerebrospinal fluid) is 
common, occurrin9 asymptomatically in 50%-60% of patients. 
Symptomatic meningitis (headaches, stiff neck) occurs in up to 15% 
of patients and resolves without sequelae in 3-10 days. Adults are 
at higher risk for this complication than children, and boys are 
more commonly affected than girls (3:1 ratio). Parotitis may be 
absent in up to 50% of such patients. Encephali tis is rare 
«0.2/1,000) and permanent sequelae or death is uncommon. 
Orchitis (testicular inflammation) is the most common 
complication in postpubertal males. It occurs in up to 20%-50% of 
postpubertal males, usually after parotitis, but may precede it, 
begin simultaneously, or occur alone. it is bilateral in up to 30% 
of affected males. There is usually abrupt onset of testicular 
swelling, tenderness, nausea , vomiting, and fever. Pain and 
swelling subside in 1 week but tenderness may last for weeks. 
Approximately 50% of patients with orchitis have some degree of 
testicular atrophy, but sterility is rare. 
Deafness caused by mumps is one of the leading causes of 
acquired sensorineural deafness in childhood. The estimated 
incidence in approximately 1 per 20,000 reported cases of mumps. 
Hearing loss is unilateral in approximately 80% of the cases and 
may be associated with vestibular reactions. onset is usually 
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Mumps continued: 
sudden and results in permanent hearing impairment. 
Oophoritis (ovarian inflammation) occurs in 5% of postpubertal 
females. It may mimic appendicitis. There is no relation to 
impaired fertility. Pancreatitis is infrequent, but occasionally 
occurs without parotitis; the hyperglycemia is transient and 
reversible. While some single instances of diabetes mellitus have 
been reported, a causal relationship has yet to be conclusively 
demonstrated. 
There is good evidence to support intrauterine infection with 
mumps as a cause of endocardial fibroelastosis or other congenital 
malformations. Increased fetal wastage, however, has been reported 
in pregnancies complicated by mumps. 
In some young adults, particularly males, monarticular 
arthritis, migratory polyarthritis, or arthralgia occurs at about 
2 weeks after onset; usually the larger joints are affected. 
Symptoms last from days to up to 3 months, but resolution is 
spontaneous and complete. Joint damage has not been reported. 
Viruria is common in mumps infections. This may be 
accomplished by abnormal renal function tests and rarely by 
nephritis, which has sometimes been fatal. 
Deaths from mumps are infrequent; 1-3.4 deaths per 10,000 




Arthritis or arthralgia may occur in up to 70% of adult women 
who contract rubella, but is rare in children or adult males. 
Fingers, wrists, and knees tend to be affected. Joint symptoms 
tend to occur about the same time or shortly after the appearance 
of the risk and may last for up to 1 month; chronic arthritis is 
rare. 
Encephalitis occurs in one in 5,000 cases, more freqUently in 
adults (especially in females) than in children. Mortality 
estimates vary from 0 to 50%. 
Hemorrhagic manifestations occur with an approximate incidence 
of 1 per 3,000 cases, occurring more often in children than adults. 
These manifestations may be .secondary to low platelet and vascular 
damage, with thrombocytopenic purpura being the most common 
manifestation. Gastrointestinal, cerebral, or intrarenal 
hemorrhage may occur. Effects may last from days to months, and 
most patients recover. 
Additional complications include orchitis, neuritis, and a 
rare late syndrome of progressive panencephalitis. 
7. Haemophilus Influenza: 
complications: 
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Invasive disease caused by H. influenzae type b can affect 
many organ systems. The most common types of invasive disease are 
meningitis, epiglottitis, pneumonia, arthritis, and cellulitis. 
Meningitis is infection of the membranes covering the brain 
and is the most common clinical manifestation of Hib disease I 
accounting for 50%-65% of cases. Hallmarks of Hib meningitis are 
fever, decreased mental status, and stiff neck. The mortality rate 
is 2%-5%, despite appropriate antimicrobial therapy. 
sequelae occur in 15%-30% of survivors. 
Neurologic 
Epiglottis is an infection and swelling of the epiglottis, the 
tissue in the throat that covers and protects the larynx during 
swallowing. Epiglottis is an infection and swelling of this 
tissue, causing life-threatening airway obstruction. 
Septic arthritis (joint infection) , cellulitis (rapid 
progressing skin lesions which usually involve the face, head, or 
neck), and pneumonia are common manifestations of invasive disease. 
Osteomyelitis (bone infection) , pericarditis (infection of the 
sac covering the heart), are less common forms of invasive disease. 
otitis media and acute bronchitis due to H. influenzae are 
generally caused by nontypable strains. Hib strains account for 




The response to poliovirus is highly variable and has been 
categorized based on the severity of clinical presentation. 
Inapparent infection without symptoms: 
Up to 95% of all polio infections are inapparent or 
subclinical. 
illness vary 
Estimates of the ratio of inapparent to paralytic 
from 50:1 to 1,000:1 (usually 200:1). Infected 
persons without symptoms shed the virus in the stool, and are able 
to transmit virus to others. 
Minor illness (abortive poliomyelitis): 
Approximately 5% (4%-8%) of polio infections consist of a 
nonspecific illness without clinical or laboratory evidence of 
central nervous system invasion and are characterized by complete 
recovery in less than a week. Three syndromes observed with this 
form of poliovirus infection are upper respiratory tract infection 
(sore throat and fever), gastrointestinal disturbances (nausea, 
vomiting, abdominal pain, constipation, or, rarely, diarrhea), and 
influenza-like illness. These syndromes are indistinguishable from 
other viral illnesses. 
Nonparalytic poliomyelitis: 
Nonparalytic aseptic meningitis (symptoms of stiffness of the 
neck, back, and/or legs) usually followed several days after a 
prodrome similar to that of minor illness occur in 1%-2% of polio 
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poliomyelitis continued: 
infections. Increased or abnormal sensations can also occur. 
Typically these symptoms will last from 2 to 10 days followed by 
complete recovery. 
paralytic poliomyelitis: 
Less than 2% of all polio infections result in a flaccid 
paralysis (usually less than 1%). Paralytic symptoms generally 
begin 1 to 10 days after prodromal symptoms and progress for 2 to 
3 days. Generally, no further paralysis occurs after the 
temperature returns to normal. The prodrome may be biphasic f 
especiallY in children, initial minor symptoms separated by a 1- to 
7-day period from more-major symptoms. Other prodromal signs and 
symptoms can include a loss of superf icial ref lexes f initially 
increased deep tendon reflexes and severs muscle aches and spasms 
in the limbs or back. The illness progresses to flaccid paralysis 
wi th diminished deep tendon reflexes which reaches a plateau 
without change for days to weeks and is usually asymmetrical. 
Many persons with paralytic poliomyelitis recover completely 
and, in most, muscle function returns to some degree. Patients 
with weakness or paralysis 12 months after onset will usually be 
left with permanent residua. 
The death-to-case ratio for paralytic polio os generally 2%-5% 
in children and up to 15%-30% in adults (depending on age). It 
increases to 25%-75% with bulbar involvement. Bulbar polio 
accounts for 2% of the cases. 
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Appendix B: Pertussis and Measles Tables of Interest 
1. Pertussis Complications by Age Group 
2. Reported Pertussis- united states, 1940-1993 
3. Reported Measles- united states, 1950-1993 
1. Pertussis Complications by Age Group: 
Pertussis 
Complications by Age Group 
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2. Reported Pertussis- united states, 1940-1993: 
Reported Pertussis - United States, 
1940-1993 
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Appendix c: Vaccine Prices (in dollars) in the United states 
1. Vaccine Prices from 1977-February 1993 
2. Federal Contract Prices for Vaccines in "Current" Dollars 
3. Private Catalog Prices for Vaccines in "Current" Dollars 
All of the information in Appendix C was taken from the 
following source: 
Institute of Medicine. Division of International Health. The 
Children's Vaccine Initiative: Achieving the Vision. Eds. 
Violaine S. Mitchell, Nalini M. Philipose, and Jay P. Sanford. 
Washington, D.C. : National Academy Press, 1993. 
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1. vaccine Prices from 1977-February 1993: 
Vaccine Prices (in dollars) in the United States 
1977-February 1993 
DTP Opy MMR Hih-CV 
CP FC CP FC CP FC CP FC 
0.19 O.ISa 1.00 0.30 6.01 2.42 NA NA 
0.22 0.15a 1.15 0.31 6.16 2.35 NA NA 
0.25 0.1Sa 1.27 0.33 6.81 2.62 NA NA 
0.30 O.ISa 1.60 0.35 7.24 2.71 NA 01A 
0.33 O.ISa 2.10 OAO 9.32 3.12 NA NA 
0.37 0.15a 2.75 OAR 10.44- 4.02 NA Nt\ 
0.45 0.4?1 3.5h 0.58 1 1.30 .. 1.70 NA N,\ 
0.99 0.65a 4.60 0.7:1 12.0R 5.·tO NA NA 
2.80 2.21 6.15 O.RO 13.53 h.B5 NA NA 
11.40 3.01 8.67 1.50 15.15 8.-l7 NA N..\ 
8.92 7.69 R07 1.36 17.RR 10.67 NA Nt\ 
11.03 8.46b 8.07 1.36 24.11 16.18 1.1 7) 11.00 
10.65 7.96 9.45 1.92 24.11 16.18 13.75 0.00 
10.65 6.91 9.74 1.92 2-l.07 14.71 1-l. ~~ ).20 
9.97 6.25 9.45 2.00 25.29 15.33 1-l.55 S.16c 
9.97 6.25 9.91 2.09 25.29 15.30 1-l.55 5.1(/ 
10.04 5.99 10.43 2.l A 25.29 15.33 15.13 .'-.J7 
Note: CP I Catalog Price; FC I Federal contract Price; NA, 
vaccine not licensed. Prices listed beginning with 1977. 
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2. Federal Contraot Prioes for vaooine in "Current" Dollars: 
Federal Contract Prices for Vaccines in "Current" Dollars 
Year Price of PI Price of PI Price of Price Indices 
OPV ($) MMR (S) DTP (S) cpr PPPI 
191 7 0.30 51 2.42 51 0.15 hI S9 
1978 0.31 54 2.35 50 0.15 oS 62 
1979 0.33 57 2.62 56 0.15 ! .. 67 
1980 0.35 61 2.71 58 0.15 S2 73 
1981 0.40 6R 3.12 66 0.15 91 81 
1982 0.48 82 4.02 86 0.15 9-: 90 
1983 0.58 100 4.70 100 0.42 100 100 
1984 0.73 125 5..10 115 0.6:' 104 109 
1985 0.80 13R 6.85 146 2.21 108 119 
1986 1.56 268 8.4"7 180 3.01 110 130 
1987 1.36 234 10.()i .."., 7.69 114 141 ....... / 
1988 1.07 184 11.74 250 3.90 118 ' C;" L~
1989 1.63 280 11.74 250 3.40 124 166 
1990 1.63 280 10.27 219 ' "'.e; 131 lSI .... .)~
1991 1. 71 294 10.89 232 1.70 13() 1% 
1992 1.80 310 10.89 232 1.70 140 208 
Note: Prices are indexed at a base year of 1993. PI, price 
index. Prices exclude the excise taxes for the Vaccine Injury 
Compensation Program that were in effect from 1988 to January 1993. 
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3. Private catalog Prices for Vaccine in "Current" Dollars: 
Private Catalog Prices for Vaccines in "Current" Dollars 
Year Price of PI Price of PI Price of Price Indices 
OPV (S) MMR (S) DTP (S) CPI PPPI 
197i 1.00 28 6.01 53 0.19 61 59 
1978 1.15 32 6.16 5S 0.22 65 62 
1979 1.27 36 6.81 00 0.25 73 67 
1980 1.60 45 7.24 6 .. ~ 0.30 82 73 
1981 2.10 59 9.32 82 0.33 91 81 
1982 2.75 77 10.44 92 0.37 97 ()O 
1983 3.56 lOO 11.30 100 OAS 100 100 
1984 4.60 129 12.08 107 0.99 104 109 
1985 6.15 173 13.53 120 2.80 lOS 119 
19R6 8.67 24-4 15.15 13-4 11.-10 110 DO 
1987 8.07 .,.,-'-'S-: 17.88 158 H.92 114 141 
1988 7.78 219 19J;7 174 {}.~'7 liS 152 
1989 9.16 257 19.67 1;4 h.09 124 166 
1990 9.45 265 19.63 1- • I .. (J.09 1~1 181 
1991 9.16 257 20.85 18~ 5.41 L'<) JC)6 
1992 9.62 270 20.85 185 5.4 i i40 208 
Note: Prices are indexed at a base year of 1993. PI, price 
index. Pr ices exclude the excise taxes for the Vaccine Injury 
Compensation Program that were in effect from 1988 to January 1993. 
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Appendix 0: An Example of the CAS A Software Program 
1. An example of Clinic site Information Form 
2. An example of the Sample Size Determination Process 
3. An example of the Data Record Input Form 





Clinic Assessment Software Application 
Version 3.0a 
Clinic Assessment Software Application (CASA) 
(1) Clinic Identification 
(2) Select Sample Size 





Created by the National Immunization Program, CDC 
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1. An example of Clinic site Information Form: 
Fl = Help PgUp = Top of Form PgDn = Menu Bar 





Clinic Review Date: / I I Common Review Date: I I / 
Beginning Assessment Month: 
24 
Ending Assessment Month: 
35 
Clinic Type: Site Name: 
Reviewer Initials: City: State: Zip: 
00000-0000 
Are You Going to Sample and Input Records From More 
Than ONE Filing System for this Clinic Site? 
(Press Fl for further explanation) 





2. An example of the Sample size Determination Process: 
You are in the Sample Size Determination Process 
Are the Immunization Records for this Practice Computerized? NO 
Press the Space Bar to Alternate between YES or No 
You are in the Sample Size Determination Process 
Are there Fewer than 200 Two-Year-Olds in this Practice? NO 
Press the Space Bar to Alternate between YES or NO 
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Sample Size Determination Process continued: 
You are in the Sample Size Determination Process 
Are the Files Organized by "Active" and "Inactive" Status:NO 
Press the Space Bar to Alternate Between YES or NO 
"Active" is Defined as All Children between 19 and 35 
Months of Age Who Have Ever Been Immunized in This Practice. 
"Inactive" is Defined as Children Who Fall Outside of the 
Age Range or who have Moved or Gone Elsewhere for Treatment. 
Are the Files Oriented by Individual or Grouped by Family? INDIVIDUAL 
Press the Space bar to Alternate between INDIVIDUAL or FAMILY 
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sample Size Determination Process continued: 
You are in the Sample Size Determination Process 
Are the Files Organized by "Active" and "Inactive" Status:NO 
What are the Total Number of Files for the Clinic: 825 
This Clinic Does not File its "Actives" Separately 
"Active" is Defined as All Children between 19 and 35 
Months of Age Who Have Ever Been Immunized in This Practice. 
"Inactive" is Defined as Children Who Fall Outside of the 
Age Range or who have Moved or Gone Elsewhere for Treatment. 
You are in the Sample Size Determination Process 
Do you have an Estimated Percentage of "Inactives" for this Clinic: YES 
Press the Space Bar to Alternate Between YES or NO 
An Estimate of the Percentage of "Inactive" Children is Necessary 
to Ascertain an Accurate Sample Size. If you do not have a Percent 
Figure then we will Provide you with an Estimation Tool. 
"Active" is Defined as All Children between 19 and 35 
Months of Age who have ever been Immunized in this Practice. 
"Inactive" is Defined as Children who Fall Outside of the 
Age Range or who have Moved or Gone Elsewhere for Treatment. 
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sample size Determination Process continued: 
You are in the Sample Size Determination Process 
Do You Have an Estimated Percentage of Missing Immunization Records: NO 
Press the Space Bar to Alternate Between YES or NO 
An Estimate of the Percentage of Children Missing 
Their Immunization Record is Necessary to Assure an 
Accurate Sample Size Count. 
"Missing" is Defined as either Lacking an Immunization Record 
or Having the Immunization Record Missplaced in some Manner. 
r------------------------------------I Press any key to continue 
A Printout is Being Assemblie~--------------------------------~ 
That are to be Used to Select the Files to Review. 
Working ....•............. 
The Following Information is Provided for this Clinic: 
The Required Sample Size to be Reviewed is: 163 
The Actual Sample Size to be Reviewed is: 165 
The Starting Record Point is: 5 
The Sampling Interval is: 5 
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3. An example of the Data Record Input Form: 
F1 = Help PgUp = Top of Form PgDn = Menu Bar DnArrow = Next Row 
II 
" \I 
Demonstration Dataset Shot Record Input Form ============~ 
Record NUmber: 142 Review Date: 02/09/94 
Last Name: 
File Origin: A 
Nedicaid: 
Last Visit Date: / / 

























































< F2/Prior > < F3/Next > <F4/Add Another> < Esc/EXit > 
~======== Valid Birthdates are Between 01/01/91 and 06/01/92 
The Last Name/Unique ID is a Mandatory-Data-Entry Field 
Appendix E: Recommended childhood Immunization Schedule USA- 1995 
:1.-
I 
Recolnmended Childhood Immunization Schedule 
United States - 1995 
Vaccines are listed under the routinely recommended ages. Shaded bars indicate range of acceptable ages for vaccination. 
Age ~ 
2 4 6 12
5 
15 18 4-6 11-12 14-16 Vaccine T Birth mas mas mas mas mas mas yrs yrs yrs 
Hepatitis B 1 II' . ' ........ ". ··>/··::r HEJ~.t .. : ...... . ... I 
U·n~~?... .. . .... 1 IIHEI-;3( 
.. 
. '. .., 
I I 
htheria, Tetanus, DTP DTP or DTP DTP DTP II Td ......... J Pertussis 2 or DTaPat15+ m DTaP 
Dip 
H. influenzae Hib Hib Hib '. Hib I 
type b 3 
Polio OPV OPV loPV . OPV 
M !asles, Mumps, MMR I MMR lfMMR Rubella 4 
I AU pregnant women should be screened for HBsAg in an early prenatal visit; infants born to HDsAg-posilive mothers should receive immunoprophylaxis for hepatitis D with 0.5 mI Hepatitis B 
Immune Globulin (IUUG) within 12 hours of birth, and 0.5 ml of either Merck Sharpe & Uohme vaccine (Recombivax liB) or of Smith Kline Beecham vaccine (Engerix-H) at a separate sUe. In these 
infants, tbe second dose of vafcine is recommended at 1 month of age and the third dose at 6 months of age. For infants of IIBsAg-negative mothers, the semnd dose of lIepat His D vacdne may he 
administered between 1 and 4 months of age, pmvided at least one month has elapsed since receipt of the first dose. The third dose is recommended be.ween 6 and 15 months of age. 
lThe fourth dose of UTP may he adminis.ered as early as 12 months of age, provided at least 6 months have elapsed since IlTPJ. Combined UTP-llib pmducts may he used when these two vaccines 
are to be administered simultaneously. OTaP (diphtheria and tetanus toxoids and at"ellular pertussis vaccine) Is licensed for use for the 4th and/or 5th dose ofl)T" vaccine in children 15 roonths of 
age or older and may be preferred for these doses in children in this age gmup. 
JThree H. ;njluellZJle type h runjugate vaccines are availahle for use in infants: IIbOC UlihTITERJ (Lellerle (lraxis); fJRP·T (ActlHIJj OmniHm] (Pasteur M~rieux, distributed by SmUhKline 
Beecham; Connaught); and "RP~(}MP (pedvaxllIDl (Merck Sharp & nohme). ChDdren who have received PRI'·OMI' at 2 and 4 months of age do no. require a dose at 6 months of age. After the 
primary infant lIib conjugate vaccine series is completed, any licensed lIih conjugate vaccine may he used as a booser dose at age 12-15 months. 
4The second dose of MMR vaccine should be administered EffllER at 4-6 years of age OR at It -12 years of age. 
S Vaccines recommended III the sef'Ond year of life (12-15 months of age) may he given H t ei ther one nr two visits. 
Approved by the Advisory Committee on Immunization Practices (ACIP), the Committee on Infectious Diseases (COlD), 
American Academy of Pediatrics (AAP), the AAP Executive Board, and the Commission on Public Health and Scientific 
Affairs (CoPHSA), American Ac~demy of Family PhYSicians (AAFP) 
